Burgerstein EPA-Kapseln 500mg, Kapseln

7680494170200 CH-49417 Kapseln
Burgerstein EPA-Kapseln 500mg, Kapseln
Burgerstein EPA-Kapseln 500mg, Kapseln
Burgerstein EPA-Kapseln 500mg, Kapseln
1 / 3
google

Article details

Package size
180
Selling units
180
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
07/03/2025
Patient information leaflet
Français
07/03/2025
Patient information leaflet
Italien
07/03/2025
Summary of Product Characteristics
Allemand
07/03/2025
Summary of Product Characteristics
Français
07/03/2025
Summary of Product Characteristics
Italien
07/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
500.0 MG Substance WIZUS
(N/A)
150.0 MG Substance WIZUS
(N/A)
90.0 MG Substance Wirkstoff (Principe actif)
(N/A)
60.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
28.0 MG Substance HBESI

Authorization holder

Antistress Aktiengesellschaft für

8640 Rapperswil-Jona

Authorization information

Swissmedic authorization number
49417
Drug name
Burgerstein EPA-Kapseln 500mg, Kapseln
Galenic form
KAPS
ATC Code
C10AX06
Authorization status
Z
Dispensing category
D
First authorization
23/05/1990
Authorization expiration date
31/12/9999
IT Number
07.12.0.
Domain
Human medicine
Field of application
Als diätetische Ergänzung der Nahrung bei erhöhten Blutfetten

Package details

Description (FR)
BURGERSTEIN EPA caps moll 500 mg bte 180 pce
Description (DE)
BURGERSTEIN EPA Weichkaps 500 mg Ds 180 Stk
Market launch
23/05/1990
Narcotic (BTM)
No

Other package sizes (1)

BURGERSTEIN EPA caps 500 mg bte 60 pce
None None
GTIN: 7680494170125
Not in V1